File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.2147/JIR.S456590
- Scopus: eid_2-s2.0-85193237806
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis
Title | Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis |
---|---|
Authors | |
Keywords | angiogenesis diabetic foot distraction osteogenesis HIF-1α tibial cortex transverse transport |
Issue Date | 1-May-2024 |
Publisher | Taylor and Francis Group |
Citation | Journal of Inflammation Research, 2024, v. 17, p. 2681-2696 How to Cite? |
Abstract | Purpose: Management of severe diabetic foot ulcers (DFUs) remains challenging. Tibial cortex transverse transport (TTT) facilitates healing and limb salvage in patients with recalcitrant DFUs. However, the underlying mechanism is largely unknown, necessitating the establishment of an animal model and mechanism exploration. Methods: Severe DFUs were induced in rats, then assigned to TTT, sham, or control groups (n=16/group). The TTT group underwent a tibial corticotomy, with 6 days each of medial and lateral transport; the sham group had a corticotomy without transport. Ulcer healing was assessed through Laser Doppler, CT angiography, histology, and immunohistochemistry. Serum HIF-1α, PDGF-BB, SDF-1, and VEGF levels were measured by ELISA. Results: The TTT group showed lower percentages of wound area, higher dermis thickness (all p < 0.001 expect for p = 0.001 for TTT vs Sham at day 6) and percentage of collagen content (all p < 0.001) than the other two groups. The TTT group had higher perfusion and vessel volume in the hindlimb (all p < 0.001). The number of CD31+ cells (all p < 0.001) and VEGFR2+ cells (at day 6, TTT vs Control, p = 0.001, TTT vs Sham, p = 0.006; at day 12, TTT vs Control, p = 0.003, TTT vs Sham, p = 0.01) were higher in the TTT group. The activity of HIF-1α, PDGF-BB, and SDF-1 was increased in the TTT group (all p < 0.001 except for SDF-1 at day 12, TTT vs Sham, p = 0.005). The TTT group had higher levels of HIF-1α, PDGF-BB, SDF-1, and VEGF in serum than the other groups (all p < 0.001). Conclusion: TTT enhanced neovascularization and perfusion at the hindlimb and accelerated healing of the severe DFUs. The underlying mechanism is related to HIF-1α-induced angiogenesis. |
Persistent Identifier | http://hdl.handle.net/10722/347174 |
ISSN | 2023 Impact Factor: 4.2 2023 SCImago Journal Rankings: 1.047 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Liu, Jie | - |
dc.contributor.author | Huang, Xiajie | - |
dc.contributor.author | Su, Hongjie | - |
dc.contributor.author | Yu, Jie | - |
dc.contributor.author | Nie, Xinyu | - |
dc.contributor.author | Liu, Kaibing | - |
dc.contributor.author | Qin, Wencong | - |
dc.contributor.author | Zhao, Yongxin | - |
dc.contributor.author | Su, Yongfeng | - |
dc.contributor.author | Kuang, Xiaocong | - |
dc.contributor.author | Chen, Di | - |
dc.contributor.author | Lu, William W | - |
dc.contributor.author | Chen, Yan | - |
dc.contributor.author | Hua, Qikai | - |
dc.date.accessioned | 2024-09-18T00:30:53Z | - |
dc.date.available | 2024-09-18T00:30:53Z | - |
dc.date.issued | 2024-05-01 | - |
dc.identifier.citation | Journal of Inflammation Research, 2024, v. 17, p. 2681-2696 | - |
dc.identifier.issn | 1178-7031 | - |
dc.identifier.uri | http://hdl.handle.net/10722/347174 | - |
dc.description.abstract | Purpose: Management of severe diabetic foot ulcers (DFUs) remains challenging. Tibial cortex transverse transport (TTT) facilitates healing and limb salvage in patients with recalcitrant DFUs. However, the underlying mechanism is largely unknown, necessitating the establishment of an animal model and mechanism exploration. Methods: Severe DFUs were induced in rats, then assigned to TTT, sham, or control groups (n=16/group). The TTT group underwent a tibial corticotomy, with 6 days each of medial and lateral transport; the sham group had a corticotomy without transport. Ulcer healing was assessed through Laser Doppler, CT angiography, histology, and immunohistochemistry. Serum HIF-1α, PDGF-BB, SDF-1, and VEGF levels were measured by ELISA. Results: The TTT group showed lower percentages of wound area, higher dermis thickness (all p < 0.001 expect for p = 0.001 for TTT vs Sham at day 6) and percentage of collagen content (all p < 0.001) than the other two groups. The TTT group had higher perfusion and vessel volume in the hindlimb (all p < 0.001). The number of CD31+ cells (all p < 0.001) and VEGFR2+ cells (at day 6, TTT vs Control, p = 0.001, TTT vs Sham, p = 0.006; at day 12, TTT vs Control, p = 0.003, TTT vs Sham, p = 0.01) were higher in the TTT group. The activity of HIF-1α, PDGF-BB, and SDF-1 was increased in the TTT group (all p < 0.001 except for SDF-1 at day 12, TTT vs Sham, p = 0.005). The TTT group had higher levels of HIF-1α, PDGF-BB, SDF-1, and VEGF in serum than the other groups (all p < 0.001). Conclusion: TTT enhanced neovascularization and perfusion at the hindlimb and accelerated healing of the severe DFUs. The underlying mechanism is related to HIF-1α-induced angiogenesis. | - |
dc.language | eng | - |
dc.publisher | Taylor and Francis Group | - |
dc.relation.ispartof | Journal of Inflammation Research | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | angiogenesis | - |
dc.subject | diabetic foot | - |
dc.subject | distraction osteogenesis | - |
dc.subject | HIF-1α | - |
dc.subject | tibial cortex transverse transport | - |
dc.title | Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis | - |
dc.type | Article | - |
dc.identifier.doi | 10.2147/JIR.S456590 | - |
dc.identifier.scopus | eid_2-s2.0-85193237806 | - |
dc.identifier.volume | 17 | - |
dc.identifier.spage | 2681 | - |
dc.identifier.epage | 2696 | - |
dc.identifier.eissn | 1178-7031 | - |
dc.identifier.issnl | 1178-7031 | - |